Manning & Napier Group's UNH Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 302,684 shares of UnitedHealth Group Incorporated (UNH) worth $100.54 M, representing 1.31% of the portfolio. First purchased in 2019-Q2, this long-term strategic position has been held for 27 quarters.
Based on 13F filings, Manning & Napier Group has maintained a strategic position in UNH, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 551,603 shares. Largest reduction occurred in Q4 2025, reducing 563,282 shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's UnitedHealth Group Incorporated (UNH) Holding Value Over Time
Track share changes against reported price movement
Quarterly UnitedHealth Group Incorporated (UNH) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -563,282 | Reduce 65.05% | 302,684 | $332.16 |
| Q3 2025 | +248,179 | Add 40.17% | 865,966 | $345.30 |
| Q2 2025 | +551,603 | Add 833.44% | 617,787 | $311.99 |
| Q1 2025 | -73,238 | Reduce 52.53% | 66,184 | $523.75 |
| Q4 2024 | -124,232 | Reduce 47.12% | 139,422 | $505.86 |
| Q3 2024 | -53,860 | Reduce 16.96% | 263,654 | $584.68 |
| Q2 2024 | +113,069 | Add 55.31% | 317,514 | $509.26 |
| Q1 2024 | +130,615 | Add 176.91% | 204,445 | $494.70 |
| Q4 2023 | +38,169 | Add 107.03% | 73,830 | $526.47 |
| Q3 2023 | -296 | Reduce 0.82% | 35,661 | $504.19 |
| Q2 2023 | +635 | Add 1.80% | 35,957 | $480.64 |
| Q1 2023 | -902 | Reduce 2.49% | 35,322 | $472.59 |
| Q4 2022 | -4,233 | Reduce 10.46% | 36,224 | $530.18 |
| Q3 2022 | -2,058 | Reduce 4.84% | 40,457 | $505.01 |
| Q2 2022 | -6,693 | Reduce 13.60% | 42,515 | $513.61 |
| Q1 2022 | -4,050 | Reduce 7.60% | 49,208 | $509.94 |
| Q4 2021 | -4,089 | Reduce 7.13% | 53,258 | $502.10 |
| Q3 2021 | -44,285 | Reduce 43.57% | 57,347 | $390.73 |
| Q2 2021 | -5,285 | Reduce 4.94% | 101,632 | $400.43 |
| Q1 2021 | +6,725 | Add 6.71% | 106,917 | $372.05 |
| Q4 2020 | +1,458 | Add 1.48% | 100,192 | $350.67 |
| Q3 2020 | -656 | Reduce 0.66% | 98,734 | $311.77 |
| Q2 2020 | +7,200 | Add 7.81% | 99,390 | $294.94 |
| Q1 2020 | -8,305 | Reduce 8.26% | 92,190 | $249.37 |
| Q4 2019 | -1,265 | Reduce 1.24% | 100,495 | $293.96 |
| Q3 2019 | -3,235 | Reduce 3.08% | 101,760 | $217.31 |
| Q2 2019 | +104,995 | New Buy | 104,995 | $243.99 |
Manning & Napier Group's UnitedHealth Group Incorporated Investment FAQs
Manning & Napier Group first purchased UnitedHealth Group Incorporated (UNH) in Q2 2019, acquiring 104,995 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held UnitedHealth Group Incorporated (UNH) for 27 quarters since Q2 2019.
Manning & Napier Group's largest addition to UnitedHealth Group Incorporated (UNH) was in Q2 2025, adding 617,787 shares worth $192.74 M.
According to the latest 13F filing for Q4 2025, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 302,684 shares of UnitedHealth Group Incorporated (UNH), valued at approximately $100.54 M.
As of the Q4 2025 filing, UnitedHealth Group Incorporated (UNH) represents approximately 1.31% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in UnitedHealth Group Incorporated (UNH) was 865,966 shares, as reported at the end of Q3 2025.